Our company|We|Our team at Biotech Company A| Company Name B specializes in the synthesis|development|production of high-quality cagrillintide peptides. Utilizing|Employing|Leveraging state-of-the-art equipment|technology|facilities, we manufacture|produce|synthesize cagrillintide peptides to meet the stringent requirements|needs|specifications of

FDA Warning: Hidden Dangers of Smuggled Tirzepatide in Peptide Markets The FDA has issued a warning about the risks of smuggled tirzepatide as the peptide therapeutics market grows rapidly. The market is expected to jump from $38 billion in 2023 to $106 billion by 2033, with an impressive 10.8% compound annual growth rate. Legitimate peptide medic